1Hasko G,Deitch E A,Szabo C,et al.Adenosine:a potential mediator of immunosuppression in multiple organ failure[J].Curr Opin Pharmacol,2002,2(4):440-444.
2Caldwell C C,Kojima H,Lukashev D,et al.Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions[J].J Immunol,2001,167(11):6140-6149.
4Loeffler D A,Keng P C,Baggs R B,et al.Lymphocy-tic infiltration and cytotoxicity under hypoxic conditions in the EMT6 mouse mammary tumor[J].Int J Cancer,1990,45(3):462-467.
5Bruns R F.Adenosine receptors.Roles and pharmacology[J].Ann N Y Acad Sci,1990,603:211-225.
7Sitkovsky M W.Use of the A(2A) adenosine receptor as a physiological immunosuppressor and to engineer inflammation in vivo[J].Biochem Pharmacol,2003,65(4):493-501.
8Blaese R M,Culver K W,Miller A D,et al.T lymphocyte-directed gene therapy for ADA-SCID:initial trial results after 4 years[J].Science,1995,270(5235):275-280.
